Brown Advisory’s AnaptysBio ANAB Stock Holding History

Brown Advisory’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-128,006	Closed	-$7.22M	–	1007
2019 Q2	$7.22M	Buy	128,006 +759	+0.6%	+$54.6K	0.02%	366
2019 Q1	$9.29M	Buy	127,247 +11,847	+10%	+$818K	0.03%	357
2018 Q4	$7.36M	Buy	115,400 +1,114	+1%	+$82.8K	0.02%	371
2018 Q3	$11.4M	Buy	114,286 +12,172	+12%	+$1.01M	0.03%	316
2018 Q2	$7.25M	Buy	102,114 +1,500	+1%	+$126K	0.02%	376
2018 Q1	$10.5M	Buy	100,614 +35,584	+55%	+$4.01M	0.03%	297
2017 Q4	$6.55M	Buy	+65,030	New	+$4.79M	0.02%	362

Other funds holding ANAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brown Advisory's ANAB Position: Q3 2019 in Review

Brown Advisory sold out of AnaptysBio (ANAB) in Q3 2019, closing a stake of 128,006 shares — an estimated $7.22M sold.

Brown Advisory first reported a position in ANAB in Q4 2017 and held it in 7 quarters. The position peaked at $11.4M in Q3 2018. 119 funds tracked by Wall St. Rank hold ANAB as of Q3 2019.

Brown Advisory reported no remaining AnaptysBio position as of Q3 2019 after selling out during the quarter.
Brown Advisory sold 128,006 AnaptysBio shares in Q3 2019, an estimated $7.22M.
Brown Advisory first reported a position in AnaptysBio in Q4 2017 and held it in 7 quarters.
Brown Advisory's AnaptysBio position peaked at $11.4M in Q3 2018.
119 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2019.

Based on Brown Advisory's 13F filing for Q3 2019, filed 14 Nov 2019.